Skip to main content
. 2020 Feb 7;11:27. doi: 10.3389/fendo.2020.00027

Table 2.

Characteristics of the study population by metabolic status.

Variable MHO
(n = 469)
MUO
(n = 732)
p-value
Male (%) 202 (36.1) 357 (63.9) 0.053
Female (%) 267 (41.6) 375 (58.4)
Age years (±SD) 11.2 (±3.0) 12.3 (±3.0) <0.001
Puberty (yes,%) 222 (47.3) 455 (62.2) <0.001
BMI, kg/m2 (±SD) 30.0 (±5.7) 30.7 (±5.0) 0.025
BMI z-score (±SD) 2.3 (±0.3) 2.2 (±0.3) 0.117
SBP, mmHg (±SD) 105.6 (±9.4) 118.3 (±13.3) <0.001
SBP z-score (±SD) −0.12 (±0.89) 0.95 (±1.21) <0.001
DBP, mmHg (±SD) 66.9 (±6.7) 72.5 (±8.3) <0.001
DBP z-score (±SD) 0.32 (±0.54) 0.80 (±0.73) <0.001
Glycaemia, mg/dl (±SD) 83.2 (±6.7) 84.9 (±7.8) <0.001
Triglycerides, mg/dl (±SD) 65.0 (±20.8) 96.0 (±46.6) <0.001
HDL cholesterol, mg/dl (±SD) 53.4 (±9.2) 46.7 (±11.0) <0.001
W-Hr, % (±SD), n = 1,138 58.0 (±7.2) 61.2 (±8.1) <0.001
Uric Acid, mg/dl (±SD), n = 1,082 4.5 (±1.1) 5.2 (±1.3) <0.001
HOMA index (±SD), n = 1,142 2.8 (±1.8) 3.7 (±2.4) <0.001